| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-722-99 | 59651-722 | HUMAN PRESCRIPTION DRUG | Clonazepam | Clonazepam | TABLET | ORAL | 20230117 | N/A | ANDA | ANDA075150 | Aurobindo Pharma Limited | CLONAZEPAM | .5 mg/1 | 1000 TABLET in 1 BOTTLE (59651-722-99) |
| 59651-723-01 | 59651-723 | HUMAN PRESCRIPTION DRUG | Clonazepam | Clonazepam | TABLET | ORAL | 20230117 | N/A | ANDA | ANDA075150 | Aurobindo Pharma Limited | CLONAZEPAM | 1 mg/1 | 100 TABLET in 1 BOTTLE (59651-723-01) |
| 59651-723-99 | 59651-723 | HUMAN PRESCRIPTION DRUG | Clonazepam | Clonazepam | TABLET | ORAL | 20230117 | N/A | ANDA | ANDA075150 | Aurobindo Pharma Limited | CLONAZEPAM | 1 mg/1 | 1000 TABLET in 1 BOTTLE (59651-723-99) |
| 59651-724-01 | 59651-724 | HUMAN PRESCRIPTION DRUG | Clonazepam | Clonazepam | TABLET | ORAL | 20230117 | N/A | ANDA | ANDA075150 | Aurobindo Pharma Limited | CLONAZEPAM | 2 mg/1 | 100 TABLET in 1 BOTTLE (59651-724-01) |
| 59651-724-05 | 59651-724 | HUMAN PRESCRIPTION DRUG | Clonazepam | Clonazepam | TABLET | ORAL | 20230117 | N/A | ANDA | ANDA075150 | Aurobindo Pharma Limited | CLONAZEPAM | 2 mg/1 | 500 TABLET in 1 BOTTLE (59651-724-05) |